KDM3A and neoplasm: JMJD1A increases or maintains expression of certain genes under hypoxia by reducing H3K9 demethylation of specific hypoxia-responsive promoters, including ADM, EDN1, HMOX1, and GDF15, resulting in increased expression of these genes and favouring tumour cell growth [97].